Global Positive Patient Identification (PPID)
Global Positive Patient Identification (PPID)

Positive Patient Identification (PPID) Comprehensive Study by End Users (Hospitals, Diagnostic Centers, Laboratories), Type (Printers, Wristbands, Labels), Characteristics (Waterproof, Laminated, Have clips or not, Labels Materials (paper or vinyl), Size Differences), Product/Hardware (Printers, Wristbands, Labels), Service (Off premise, On-premise, Cloud), Patient (Baby, Pediatric, Maternity, Adult) Players and Region - Global Market Outlook to 2026

Positive Patient Identification (PPID) Market Segmented into XX Submarkets. | Forecast Years: 2020- 2026  

Jun 2021 Edition 217 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Positive Patient Identification (PPID) Market Overview:
Positive patient identification (PPID) is an approach to maintaining a strategic distance from patient misidentification for the prevention of medical mistakes, which include errors in medication, transfusion, and testing, as well as wrong-person procedures and the discharge of newborn babies to the wrong family. Since the turn of the second millennium, healthcare authorizing bodies and the World Health Organization have emphasized the significance of tracking patients, medications, and information through PPID. Some of the players profiled in the study are Taylor Communications, Inc. (United States), Imprivata, Inc. (United States), ZIH Corp (United States), Identification Systems Group (United States), RightPatient Inc. (United States), Cerner Corporation (United States), Endur ID Incorporated (united States), GBS Corp (United States) and SATO Australia Pty Ltd. (Australia).

On the basis of geography, the market of Positive Patient Identification (PPID) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Positive Patient Identification (PPID) market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Technological Advancements in Medical Science

Influencing Trend
  • Shift towards Cloud-Based Positive Patient Identification Solution
  • Shift towards Biometric Positive Patient Identification Solutions
  • Emphasis on Integration Capabilities

Restraints
  • High Initial Setup Cost
  • Limitations in Processes result in Inaccurate Patient Identification

Opportunities
  • Untapped Area of Developed Nation

Challenges
  • Generating and Implementing Unique Patient Identifiers (UPIs)




The companies are exploring the market by adopting expansions, investments, and new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Target Audience:
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations and End-Use Industries

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Positive Patient Identification (PPID) market on the basis of product [] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Positive Patient Identification (PPID) market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Positive Patient Identification (PPID) industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are PDC Healthcare (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Positive Patient Identification (PPID) market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Report Objectives / Segmentation Covered
By End Users
  • Hospitals
  • Diagnostic Centers
  • Laboratories

By Type
  • Printers
  • Wristbands
  • Labels

By Characteristics
  • Waterproof
  • Laminated
  • Have clips or not
  • Labels Materials (paper or vinyl)
  • Size Differences

By Product/Hardware
  • Printers
  • Wristbands
  • Labels

By Service
  • Off premise
  • On-premise
  • Cloud

By Patient
  • Baby
  • Pediatric
  • Maternity
  • Adult

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Technological Advancements in Medical Science
    • 3.3. Market Challenges
      • 3.3.1. Generating and Implementing Unique Patient Identifiers (UPIs)
    • 3.4. Market Trends
      • 3.4.1. Shift towards Cloud-Based Positive Patient Identification Solution
      • 3.4.2. Shift towards Biometric Positive Patient Identification Solutions
      • 3.4.3. Emphasis on Integration Capabilities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Positive Patient Identification (PPID), by End Users, Type, Characteristics, Product/Hardware, Service, Patient and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Positive Patient Identification (PPID) (Value)
      • 5.2.1. Global Positive Patient Identification (PPID) by: Type (Value)
        • 5.2.1.1. Printers
        • 5.2.1.2. Wristbands
        • 5.2.1.3. Labels
      • 5.2.2. Global Positive Patient Identification (PPID) by: End Users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Diagnostic Centers
        • 5.2.2.3. Laboratories
      • 5.2.3. Global Positive Patient Identification (PPID) by: Type (Value)
        • 5.2.3.1. Printers
        • 5.2.3.2. Wristbands
        • 5.2.3.3. Labels
      • 5.2.4. Global Positive Patient Identification (PPID) by: Characteristics (Value)
        • 5.2.4.1. Waterproof
        • 5.2.4.2. Laminated
        • 5.2.4.3. Have clips or not
        • 5.2.4.4. Labels Materials (paper or vinyl)
        • 5.2.4.5. Size Differences
      • 5.2.5. Global Positive Patient Identification (PPID) by: Product/Hardware (Value)
        • 5.2.5.1. Printers
        • 5.2.5.2. Wristbands
        • 5.2.5.3. Labels
      • 5.2.6. Global Positive Patient Identification (PPID) by: Service (Value)
        • 5.2.6.1. Off premise
        • 5.2.6.2. On-premise
        • 5.2.6.3. Cloud
      • 5.2.7. Global Positive Patient Identification (PPID) by: Patient (Value)
        • 5.2.7.1. Baby
        • 5.2.7.2. Pediatric
        • 5.2.7.3. Maternity
        • 5.2.7.4. Adult
      • 5.2.8. Global Positive Patient Identification (PPID) Region
        • 5.2.8.1. South America
          • 5.2.8.1.1. Brazil
          • 5.2.8.1.2. Argentina
          • 5.2.8.1.3. Rest of South America
        • 5.2.8.2. Asia Pacific
          • 5.2.8.2.1. China
          • 5.2.8.2.2. Japan
          • 5.2.8.2.3. India
          • 5.2.8.2.4. South Korea
          • 5.2.8.2.5. Taiwan
          • 5.2.8.2.6. Australia
          • 5.2.8.2.7. Rest of Asia-Pacific
        • 5.2.8.3. Europe
          • 5.2.8.3.1. Germany
          • 5.2.8.3.2. France
          • 5.2.8.3.3. Italy
          • 5.2.8.3.4. United Kingdom
          • 5.2.8.3.5. Netherlands
          • 5.2.8.3.6. Rest of Europe
        • 5.2.8.4. MEA
          • 5.2.8.4.1. Middle East
          • 5.2.8.4.2. Africa
        • 5.2.8.5. North America
          • 5.2.8.5.1. United States
          • 5.2.8.5.2. Canada
          • 5.2.8.5.3. Mexico
  • 6. Positive Patient Identification (PPID): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Taylor Communications, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Imprivata, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ZIH Corp (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Identification Systems Group (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. RightPatient Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cerner Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Endur ID Incorporated (united States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GBS Corp (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. SATO Australia Pty Ltd. (Australia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Positive Patient Identification (PPID) Sale, by End Users, Type, Characteristics, Product/Hardware, Service, Patient and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Positive Patient Identification (PPID) (Value)
      • 7.2.1. Global Positive Patient Identification (PPID) by: Type (Value)
        • 7.2.1.1. Printers
        • 7.2.1.2. Wristbands
        • 7.2.1.3. Labels
      • 7.2.2. Global Positive Patient Identification (PPID) by: End Users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Diagnostic Centers
        • 7.2.2.3. Laboratories
      • 7.2.3. Global Positive Patient Identification (PPID) by: Type (Value)
        • 7.2.3.1. Printers
        • 7.2.3.2. Wristbands
        • 7.2.3.3. Labels
      • 7.2.4. Global Positive Patient Identification (PPID) by: Characteristics (Value)
        • 7.2.4.1. Waterproof
        • 7.2.4.2. Laminated
        • 7.2.4.3. Have clips or not
        • 7.2.4.4. Labels Materials (paper or vinyl)
        • 7.2.4.5. Size Differences
      • 7.2.5. Global Positive Patient Identification (PPID) by: Product/Hardware (Value)
        • 7.2.5.1. Printers
        • 7.2.5.2. Wristbands
        • 7.2.5.3. Labels
      • 7.2.6. Global Positive Patient Identification (PPID) by: Service (Value)
        • 7.2.6.1. Off premise
        • 7.2.6.2. On-premise
        • 7.2.6.3. Cloud
      • 7.2.7. Global Positive Patient Identification (PPID) by: Patient (Value)
        • 7.2.7.1. Baby
        • 7.2.7.2. Pediatric
        • 7.2.7.3. Maternity
        • 7.2.7.4. Adult
      • 7.2.8. Global Positive Patient Identification (PPID) Region
        • 7.2.8.1. South America
          • 7.2.8.1.1. Brazil
          • 7.2.8.1.2. Argentina
          • 7.2.8.1.3. Rest of South America
        • 7.2.8.2. Asia Pacific
          • 7.2.8.2.1. China
          • 7.2.8.2.2. Japan
          • 7.2.8.2.3. India
          • 7.2.8.2.4. South Korea
          • 7.2.8.2.5. Taiwan
          • 7.2.8.2.6. Australia
          • 7.2.8.2.7. Rest of Asia-Pacific
        • 7.2.8.3. Europe
          • 7.2.8.3.1. Germany
          • 7.2.8.3.2. France
          • 7.2.8.3.3. Italy
          • 7.2.8.3.4. United Kingdom
          • 7.2.8.3.5. Netherlands
          • 7.2.8.3.6. Rest of Europe
        • 7.2.8.4. MEA
          • 7.2.8.4.1. Middle East
          • 7.2.8.4.2. Africa
        • 7.2.8.5. North America
          • 7.2.8.5.1. United States
          • 7.2.8.5.2. Canada
          • 7.2.8.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Positive Patient Identification (PPID): by Type(USD Million)
  • Table 2. Positive Patient Identification (PPID) Printers , by Region USD Million (2014-2019)
  • Table 3. Positive Patient Identification (PPID) Wristbands , by Region USD Million (2014-2019)
  • Table 4. Positive Patient Identification (PPID) Labels , by Region USD Million (2014-2019)
  • Table 5. Positive Patient Identification (PPID): by End Users(USD Million)
  • Table 6. Positive Patient Identification (PPID) Hospitals , by Region USD Million (2014-2019)
  • Table 7. Positive Patient Identification (PPID) Diagnostic Centers , by Region USD Million (2014-2019)
  • Table 8. Positive Patient Identification (PPID) Laboratories , by Region USD Million (2014-2019)
  • Table 9. Positive Patient Identification (PPID): by Type(USD Million)
  • Table 10. Positive Patient Identification (PPID) Printers , by Region USD Million (2014-2019)
  • Table 11. Positive Patient Identification (PPID) Wristbands , by Region USD Million (2014-2019)
  • Table 12. Positive Patient Identification (PPID) Labels , by Region USD Million (2014-2019)
  • Table 13. Positive Patient Identification (PPID): by Characteristics(USD Million)
  • Table 14. Positive Patient Identification (PPID) Waterproof , by Region USD Million (2014-2019)
  • Table 15. Positive Patient Identification (PPID) Laminated , by Region USD Million (2014-2019)
  • Table 16. Positive Patient Identification (PPID) Have clips or not , by Region USD Million (2014-2019)
  • Table 17. Positive Patient Identification (PPID) Labels Materials (paper or vinyl) , by Region USD Million (2014-2019)
  • Table 18. Positive Patient Identification (PPID) Size Differences , by Region USD Million (2014-2019)
  • Table 19. Positive Patient Identification (PPID): by Product/Hardware(USD Million)
  • Table 20. Positive Patient Identification (PPID) Printers , by Region USD Million (2014-2019)
  • Table 21. Positive Patient Identification (PPID) Wristbands , by Region USD Million (2014-2019)
  • Table 22. Positive Patient Identification (PPID) Labels , by Region USD Million (2014-2019)
  • Table 23. Positive Patient Identification (PPID): by Service(USD Million)
  • Table 24. Positive Patient Identification (PPID) Off premise , by Region USD Million (2014-2019)
  • Table 25. Positive Patient Identification (PPID) On-premise , by Region USD Million (2014-2019)
  • Table 26. Positive Patient Identification (PPID) Cloud , by Region USD Million (2014-2019)
  • Table 27. Positive Patient Identification (PPID): by Patient(USD Million)
  • Table 28. Positive Patient Identification (PPID) Baby , by Region USD Million (2014-2019)
  • Table 29. Positive Patient Identification (PPID) Pediatric , by Region USD Million (2014-2019)
  • Table 30. Positive Patient Identification (PPID) Maternity , by Region USD Million (2014-2019)
  • Table 31. Positive Patient Identification (PPID) Adult , by Region USD Million (2014-2019)
  • Table 32. South America Positive Patient Identification (PPID), by Country USD Million (2014-2019)
  • Table 33. South America Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 34. South America Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 35. South America Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 36. South America Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 37. South America Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 38. South America Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 39. Brazil Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 40. Brazil Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 41. Brazil Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 42. Brazil Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 43. Brazil Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 44. Brazil Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 45. Argentina Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 46. Argentina Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 47. Argentina Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 48. Argentina Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 49. Argentina Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 50. Argentina Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 51. Rest of South America Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 52. Rest of South America Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 53. Rest of South America Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 54. Rest of South America Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 55. Rest of South America Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 56. Rest of South America Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 57. Asia Pacific Positive Patient Identification (PPID), by Country USD Million (2014-2019)
  • Table 58. Asia Pacific Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 59. Asia Pacific Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 60. Asia Pacific Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 61. Asia Pacific Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 62. Asia Pacific Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 63. Asia Pacific Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 64. China Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 65. China Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 66. China Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 67. China Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 68. China Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 69. China Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 70. Japan Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 71. Japan Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 72. Japan Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 73. Japan Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 74. Japan Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 75. Japan Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 76. India Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 77. India Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 78. India Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 79. India Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 80. India Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 81. India Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 82. South Korea Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 83. South Korea Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 84. South Korea Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 85. South Korea Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 86. South Korea Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 87. South Korea Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 88. Taiwan Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 89. Taiwan Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 90. Taiwan Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 91. Taiwan Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 92. Taiwan Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 93. Taiwan Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 94. Australia Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 95. Australia Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 96. Australia Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 97. Australia Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 98. Australia Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 99. Australia Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 100. Rest of Asia-Pacific Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 101. Rest of Asia-Pacific Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 102. Rest of Asia-Pacific Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 103. Rest of Asia-Pacific Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 104. Rest of Asia-Pacific Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 105. Rest of Asia-Pacific Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 106. Europe Positive Patient Identification (PPID), by Country USD Million (2014-2019)
  • Table 107. Europe Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 108. Europe Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 109. Europe Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 110. Europe Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 111. Europe Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 112. Europe Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 113. Germany Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 114. Germany Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 115. Germany Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 116. Germany Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 117. Germany Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 118. Germany Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 119. France Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 120. France Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 121. France Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 122. France Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 123. France Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 124. France Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 125. Italy Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 126. Italy Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 127. Italy Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 128. Italy Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 129. Italy Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 130. Italy Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 131. United Kingdom Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 132. United Kingdom Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 133. United Kingdom Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 134. United Kingdom Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 135. United Kingdom Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 136. United Kingdom Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 137. Netherlands Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 138. Netherlands Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 139. Netherlands Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 140. Netherlands Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 141. Netherlands Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 142. Netherlands Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 143. Rest of Europe Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 144. Rest of Europe Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 145. Rest of Europe Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 146. Rest of Europe Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 147. Rest of Europe Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 148. Rest of Europe Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 149. MEA Positive Patient Identification (PPID), by Country USD Million (2014-2019)
  • Table 150. MEA Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 151. MEA Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 152. MEA Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 153. MEA Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 154. MEA Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 155. MEA Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 156. Middle East Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 157. Middle East Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 158. Middle East Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 159. Middle East Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 160. Middle East Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 161. Middle East Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 162. Africa Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 163. Africa Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 164. Africa Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 165. Africa Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 166. Africa Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 167. Africa Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 168. North America Positive Patient Identification (PPID), by Country USD Million (2014-2019)
  • Table 169. North America Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 170. North America Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 171. North America Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 172. North America Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 173. North America Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 174. North America Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 175. United States Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 176. United States Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 177. United States Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 178. United States Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 179. United States Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 180. United States Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 181. Canada Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 182. Canada Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 183. Canada Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 184. Canada Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 185. Canada Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 186. Canada Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 187. Mexico Positive Patient Identification (PPID), by End Users USD Million (2014-2019)
  • Table 188. Mexico Positive Patient Identification (PPID), by Type USD Million (2014-2019)
  • Table 189. Mexico Positive Patient Identification (PPID), by Characteristics USD Million (2014-2019)
  • Table 190. Mexico Positive Patient Identification (PPID), by Product/Hardware USD Million (2014-2019)
  • Table 191. Mexico Positive Patient Identification (PPID), by Service USD Million (2014-2019)
  • Table 192. Mexico Positive Patient Identification (PPID), by Patient USD Million (2014-2019)
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Positive Patient Identification (PPID): by Type(USD Million)
  • Table 203. Positive Patient Identification (PPID) Printers , by Region USD Million (2021-2026)
  • Table 204. Positive Patient Identification (PPID) Wristbands , by Region USD Million (2021-2026)
  • Table 205. Positive Patient Identification (PPID) Labels , by Region USD Million (2021-2026)
  • Table 206. Positive Patient Identification (PPID): by End Users(USD Million)
  • Table 207. Positive Patient Identification (PPID) Hospitals , by Region USD Million (2021-2026)
  • Table 208. Positive Patient Identification (PPID) Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 209. Positive Patient Identification (PPID) Laboratories , by Region USD Million (2021-2026)
  • Table 210. Positive Patient Identification (PPID): by Type(USD Million)
  • Table 211. Positive Patient Identification (PPID) Printers , by Region USD Million (2021-2026)
  • Table 212. Positive Patient Identification (PPID) Wristbands , by Region USD Million (2021-2026)
  • Table 213. Positive Patient Identification (PPID) Labels , by Region USD Million (2021-2026)
  • Table 214. Positive Patient Identification (PPID): by Characteristics(USD Million)
  • Table 215. Positive Patient Identification (PPID) Waterproof , by Region USD Million (2021-2026)
  • Table 216. Positive Patient Identification (PPID) Laminated , by Region USD Million (2021-2026)
  • Table 217. Positive Patient Identification (PPID) Have clips or not , by Region USD Million (2021-2026)
  • Table 218. Positive Patient Identification (PPID) Labels Materials (paper or vinyl) , by Region USD Million (2021-2026)
  • Table 219. Positive Patient Identification (PPID) Size Differences , by Region USD Million (2021-2026)
  • Table 220. Positive Patient Identification (PPID): by Product/Hardware(USD Million)
  • Table 221. Positive Patient Identification (PPID) Printers , by Region USD Million (2021-2026)
  • Table 222. Positive Patient Identification (PPID) Wristbands , by Region USD Million (2021-2026)
  • Table 223. Positive Patient Identification (PPID) Labels , by Region USD Million (2021-2026)
  • Table 224. Positive Patient Identification (PPID): by Service(USD Million)
  • Table 225. Positive Patient Identification (PPID) Off premise , by Region USD Million (2021-2026)
  • Table 226. Positive Patient Identification (PPID) On-premise , by Region USD Million (2021-2026)
  • Table 227. Positive Patient Identification (PPID) Cloud , by Region USD Million (2021-2026)
  • Table 228. Positive Patient Identification (PPID): by Patient(USD Million)
  • Table 229. Positive Patient Identification (PPID) Baby , by Region USD Million (2021-2026)
  • Table 230. Positive Patient Identification (PPID) Pediatric , by Region USD Million (2021-2026)
  • Table 231. Positive Patient Identification (PPID) Maternity , by Region USD Million (2021-2026)
  • Table 232. Positive Patient Identification (PPID) Adult , by Region USD Million (2021-2026)
  • Table 233. South America Positive Patient Identification (PPID), by Country USD Million (2021-2026)
  • Table 234. South America Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 235. South America Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 236. South America Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 237. South America Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 238. South America Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 239. South America Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 240. Brazil Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 241. Brazil Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 242. Brazil Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 243. Brazil Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 244. Brazil Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 245. Brazil Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 246. Argentina Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 247. Argentina Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 248. Argentina Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 249. Argentina Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 250. Argentina Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 251. Argentina Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 252. Rest of South America Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 253. Rest of South America Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 254. Rest of South America Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 255. Rest of South America Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 256. Rest of South America Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 257. Rest of South America Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 258. Asia Pacific Positive Patient Identification (PPID), by Country USD Million (2021-2026)
  • Table 259. Asia Pacific Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 260. Asia Pacific Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 261. Asia Pacific Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 262. Asia Pacific Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 263. Asia Pacific Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 264. Asia Pacific Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 265. China Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 266. China Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 267. China Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 268. China Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 269. China Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 270. China Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 271. Japan Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 272. Japan Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 273. Japan Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 274. Japan Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 275. Japan Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 276. Japan Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 277. India Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 278. India Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 279. India Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 280. India Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 281. India Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 282. India Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 283. South Korea Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 284. South Korea Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 285. South Korea Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 286. South Korea Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 287. South Korea Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 288. South Korea Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 289. Taiwan Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 290. Taiwan Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 291. Taiwan Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 292. Taiwan Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 293. Taiwan Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 294. Taiwan Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 295. Australia Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 296. Australia Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 297. Australia Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 298. Australia Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 299. Australia Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 300. Australia Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 301. Rest of Asia-Pacific Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 302. Rest of Asia-Pacific Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 303. Rest of Asia-Pacific Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 304. Rest of Asia-Pacific Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 305. Rest of Asia-Pacific Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 306. Rest of Asia-Pacific Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 307. Europe Positive Patient Identification (PPID), by Country USD Million (2021-2026)
  • Table 308. Europe Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 309. Europe Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 310. Europe Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 311. Europe Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 312. Europe Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 313. Europe Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 314. Germany Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 315. Germany Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 316. Germany Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 317. Germany Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 318. Germany Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 319. Germany Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 320. France Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 321. France Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 322. France Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 323. France Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 324. France Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 325. France Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 326. Italy Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 327. Italy Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 328. Italy Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 329. Italy Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 330. Italy Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 331. Italy Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 332. United Kingdom Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 333. United Kingdom Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 334. United Kingdom Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 335. United Kingdom Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 336. United Kingdom Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 337. United Kingdom Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 338. Netherlands Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 339. Netherlands Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 340. Netherlands Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 341. Netherlands Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 342. Netherlands Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 343. Netherlands Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 344. Rest of Europe Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 345. Rest of Europe Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 346. Rest of Europe Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 347. Rest of Europe Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 348. Rest of Europe Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 349. Rest of Europe Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 350. MEA Positive Patient Identification (PPID), by Country USD Million (2021-2026)
  • Table 351. MEA Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 352. MEA Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 353. MEA Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 354. MEA Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 355. MEA Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 356. MEA Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 357. Middle East Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 358. Middle East Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 359. Middle East Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 360. Middle East Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 361. Middle East Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 362. Middle East Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 363. Africa Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 364. Africa Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 365. Africa Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 366. Africa Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 367. Africa Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 368. Africa Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 369. North America Positive Patient Identification (PPID), by Country USD Million (2021-2026)
  • Table 370. North America Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 371. North America Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 372. North America Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 373. North America Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 374. North America Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 375. North America Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 376. United States Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 377. United States Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 378. United States Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 379. United States Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 380. United States Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 381. United States Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 382. Canada Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 383. Canada Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 384. Canada Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 385. Canada Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 386. Canada Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 387. Canada Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 388. Mexico Positive Patient Identification (PPID), by End Users USD Million (2021-2026)
  • Table 389. Mexico Positive Patient Identification (PPID), by Type USD Million (2021-2026)
  • Table 390. Mexico Positive Patient Identification (PPID), by Characteristics USD Million (2021-2026)
  • Table 391. Mexico Positive Patient Identification (PPID), by Product/Hardware USD Million (2021-2026)
  • Table 392. Mexico Positive Patient Identification (PPID), by Service USD Million (2021-2026)
  • Table 393. Mexico Positive Patient Identification (PPID), by Patient USD Million (2021-2026)
  • Table 394. Research Programs/Design for This Report
  • Table 395. Key Data Information from Secondary Sources
  • Table 396. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Positive Patient Identification (PPID): by Type USD Million (2014-2019)
  • Figure 5. Global Positive Patient Identification (PPID): by End Users USD Million (2014-2019)
  • Figure 6. Global Positive Patient Identification (PPID): by Type USD Million (2014-2019)
  • Figure 7. Global Positive Patient Identification (PPID): by Characteristics USD Million (2014-2019)
  • Figure 8. Global Positive Patient Identification (PPID): by Product/Hardware USD Million (2014-2019)
  • Figure 9. Global Positive Patient Identification (PPID): by Service USD Million (2014-2019)
  • Figure 10. Global Positive Patient Identification (PPID): by Patient USD Million (2014-2019)
  • Figure 11. South America Positive Patient Identification (PPID) Share (%), by Country
  • Figure 12. Asia Pacific Positive Patient Identification (PPID) Share (%), by Country
  • Figure 13. Europe Positive Patient Identification (PPID) Share (%), by Country
  • Figure 14. MEA Positive Patient Identification (PPID) Share (%), by Country
  • Figure 15. North America Positive Patient Identification (PPID) Share (%), by Country
  • Figure 16. Global Positive Patient Identification (PPID) share by Players 2019 (%)
  • Figure 17. Global Positive Patient Identification (PPID) share by Players (Top 3) 2019(%)
  • Figure 18. Global Positive Patient Identification (PPID) share by Players (Top 5) 2019(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. Taylor Communications, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Taylor Communications, Inc. (United States) Revenue: by Geography 2019
  • Figure 22. Imprivata, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Imprivata, Inc. (United States) Revenue: by Geography 2019
  • Figure 24. ZIH Corp (United States) Revenue, Net Income and Gross profit
  • Figure 25. ZIH Corp (United States) Revenue: by Geography 2019
  • Figure 26. Identification Systems Group (United States) Revenue, Net Income and Gross profit
  • Figure 27. Identification Systems Group (United States) Revenue: by Geography 2019
  • Figure 28. RightPatient Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. RightPatient Inc. (United States) Revenue: by Geography 2019
  • Figure 30. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cerner Corporation (United States) Revenue: by Geography 2019
  • Figure 32. Endur ID Incorporated (united States) Revenue, Net Income and Gross profit
  • Figure 33. Endur ID Incorporated (united States) Revenue: by Geography 2019
  • Figure 34. GBS Corp (United States) Revenue, Net Income and Gross profit
  • Figure 35. GBS Corp (United States) Revenue: by Geography 2019
  • Figure 36. SATO Australia Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 37. SATO Australia Pty Ltd. (Australia) Revenue: by Geography 2019
  • Figure 38. Global Positive Patient Identification (PPID): by Type USD Million (2021-2026)
  • Figure 39. Global Positive Patient Identification (PPID): by End Users USD Million (2021-2026)
  • Figure 40. Global Positive Patient Identification (PPID): by Type USD Million (2021-2026)
  • Figure 41. Global Positive Patient Identification (PPID): by Characteristics USD Million (2021-2026)
  • Figure 42. Global Positive Patient Identification (PPID): by Product/Hardware USD Million (2021-2026)
  • Figure 43. Global Positive Patient Identification (PPID): by Service USD Million (2021-2026)
  • Figure 44. Global Positive Patient Identification (PPID): by Patient USD Million (2021-2026)
  • Figure 45. South America Positive Patient Identification (PPID) Share (%), by Country
  • Figure 46. Asia Pacific Positive Patient Identification (PPID) Share (%), by Country
  • Figure 47. Europe Positive Patient Identification (PPID) Share (%), by Country
  • Figure 48. MEA Positive Patient Identification (PPID) Share (%), by Country
  • Figure 49. North America Positive Patient Identification (PPID) Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Taylor Communications, Inc. (United States)
  • Imprivata, Inc. (United States)
  • ZIH Corp (United States)
  • Identification Systems Group (United States)
  • RightPatient Inc. (United States)
  • Cerner Corporation (United States)
  • Endur ID Incorporated (united States)
  • GBS Corp (United States)
  • SATO Australia Pty Ltd. (Australia)
Additional players considered in the study are as follows:
PDC Healthcare (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation